Latest John Dick Stories
Cancer researchers led by stem cell scientist Dr. John Dick have discovered a pre-leukemic stem cell that may be the first step in initiating disease and also the culprit that evades therapy and triggers relapse in patients with acute myeloid leukemia (AML).
Scientists and surgeons at Princess Margaret Cancer Centre have discovered a promising new approach to treating colorectal cancer by disarming the gene that drives self-renewal in stem cells that are the root cause of disease, resistance to treatment and relapse.
Cancer scientists led by Dr. John Dick at the Princess Margaret Cancer Centre have found a way to follow single tumor cells and observe their growth over time.
Cancer scientists have long debated whether all cells within a tumour are equal or whether some cancer cells are more potent - a question that has been highly investigated in experimental models in the last decade.
To view the Social Media Release, click here: http://smr.newswire.ca/en/canadian-cancer-society/when-cancer-strikes-the-most-vulnerable TORONTO, April 27 /PRNewswire/ - A new Canadian Cancer Society-funded study will investigate the genetic puzzle of a devastating nervous system cancer that strikes infants, and identify potential new treatments for the disease.
Dr. John Dick, Senior Scientist at the Ontario Cancer Institute, the research arm of Princess Margaret Hospital, co-led a multinational team that has developed the first leukemia therapy that targets a protein, CD123, on the surface of cancer stem cells that drive acute myeloid leukemia (AML), which is an aggressive disease with a poor outcome.
By Sheryl Ubelacker, Health Reporter, THE CANADIAN PRESS TORONTO - The federal government is investing more than $100 million into cancer stem cell research in partnership with California, Health Minister Tony Clement said Wednesday.
- A transitional zone between two communities containing the characteristic species of each.